JEFFREY ANDERSON, University of Utah, Salt Lake City
COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis
REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans
The hope of refining treatments for cardiovascular disease by genotyping patients to detect individual sensitivities to particular medical therapies was brought a step closer at the ACC meeting in New Orleans by results from a study using a rapid genothype test. Jeffrey Anderson told Peter Goodwin about the assay they’ve been investigating which indicates required dosing of warfarin.
Cardiologists and doctors whose patients have cardiovascular disease in any form receive up-to-date audio information via the audio journal of
[...] Jeffrey Anderson. Douglas Zipes. JEFFREY ANDERSON, University of Utah, Salt Lake City COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis. REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans … …more [...]
[...] Jeffrey Anderson. Douglas Zipes. JEFFREY ANDERSON, University of Utah, Salt Lake City COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis. REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans … …more [...]